Desmidt, Thomas http://orcid.org/0000-0003-0949-8389
Dujardin, Paul-Armand
Andersson, Frédéric
Brizard, Bruno http://orcid.org/0000-0002-0110-822X
Réméniéras, Jean-Pierre
Gissot, Valérie http://orcid.org/0000-0002-0091-8159
Arlicot, Nicolas http://orcid.org/0000-0001-7087-2312
Barantin, Laurent http://orcid.org/0000-0002-5119-658X
Espitalier, Fabien
Belzung, Catherine http://orcid.org/0000-0001-6095-5974
Tanti, Arnaud http://orcid.org/0000-0003-4249-2317
Robert, Gabriel http://orcid.org/0000-0003-2490-0700
Bulteau, Samuel
Gallet, Quentin
Kazour, François
Cognet, Sandrine
Camus, Vincent http://orcid.org/0000-0002-6845-221X
El-Hage, Wissam
Poupin, Pierre http://orcid.org/0000-0003-1946-1686
Karim, Helmet T. http://orcid.org/0000-0002-9286-0694
Article History
Received: 21 February 2023
Revised: 1 August 2023
Accepted: 3 August 2023
First Online: 17 August 2023
Competing interests
: TD reports personal fees from Janssen and Lundbeck. WEH reports personal fees from Air Liquide, Eisai, Janssen, Lundbeck, Otsuka, UCB and Chugai. VC reports personal fees from Janssen, Bristol Myers Squibb and AA Pharma. All other authors declare no competing interests.